English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Jaguar8 commented on a stock · Dec 3, 2024 20:07

NEWS

Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
6 minutes ago, 4:00 AM PST
Via GlobeNewswire
ROIVROIVW
Share
• Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis
• Further development of namilumab for the treatment of sarcoidosis will be discontinued
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3404 Views
Comment
Sign in to post a comment
    avatar
    Jaguar8
    Spread kindness and love. Life is short. Don’t let greed eat you.
    6666
    Followers
    44
    Following
    72K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartLatest Price
    NVDA
    NVIDIA
    -- 131.760
    TSLA
    Tesla
    -- 396.360
    RGTI
    Rigetti Computing
    -- 8.9500
    AMD
    Advanced Micro Devices
    -- 116.090
    PLTR
    Palantir
    -- 65.910
    News
    Trump's Executive Orders Will Focus on the Border, Energy
    02:05
    Trump Names Uyeda Acting SEC Chair, Regulators Get Ready For Crypto Makeover
    06:15
    Chinese Asset Sentiment Shows Signs of Recovery
    Jan 20 19:25
    Trump Sworn In As 47th President, Declares 'Golden Age Of America Begins Right Now'
    01:46
    Trump: Will Establish 'external Revenue Service'
    01:25
    Discussing
    Trump 2.0 countdown: What's the next big opportunity in the markets?
    ▪️Could Trump's cryptocurrency policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese Show More
    Trump 2.0 Opportunity Preview: Guess the market winner before the president takes office!